About Altis Biosystems
Altis Biosystems is a private company based in Durham, North Carolina. It has reported $6,593,034 raised in three offerings on Form D since January 2020. Its chief executive is Benjamin Scruggs.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | Apr 7, 2025 | $2,126,307of $2.2M target | 9 | $236K | EquityRule 506(b) | Form D ↗ |
| Jul 20, 2022 | Aug 2, 2022 | $1,363,658of $5.0M target | 17 | $80,215 | EquityRule 506(b) | Form D ↗ |
| Dec 30, 2019 | Jan 17, 2020amended Jul 22, 2020 | $3,103,069fully sold | 42 | $73,883 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, three offerings | $6,593,034 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Altis Biosystems's Form D filed Apr 7, 2025.
CP
Christopher Perkins
Director
MD
Michael Dial
Director
CS
Christopher Sims
Executive officer
BS
Benjamin Scruggs
Chief Executive Officer and director
JS
Jimmy Smedley
Executive officer
SM
Susan Mahony
Director
KC
Kevin Causey
Director
Earlier filings also listed Samuel Franklin (director, last listed Aug 2022), Michael Biron (chief executive officer and director, last listed Aug 2022) and Joseph McMahon (director, last listed Aug 2022).